Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03025763 · ClinicalTrials.gov registry record
Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones
A clinical trial of Craniosynostosis, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- 2,145
- Enrollment target
- 20
- Study locations
NCT03025763: Active study of Craniosynostosis, sponsored by Icahn School of Medicine at Mount Sinai.
NCT03025763 is a study of Craniosynostosis that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 2,145 participants. The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03025763, a study of Craniosynostosis, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- 2,145 participants
- Enrollment target
- 20
- Study locations
Study Summary
Craniosynostosis (CS) is a common malformation occurring in \~4 per 10,000 live births in which the sutures between skull bones close too early, causing long-term problems with brain and skull growth. Infants with CS typically require extensive surgical treatment and may experience many perioperative complications, including hemorrhage and re-synostosis. Even with successful surgery, children can experience developmental and learning disabilities or vision problems. Most often, CS appears as isolated nonsyndromic CS (NSC). Of the several subtypes of CS, unilateral or bilateral fusion of the coronal suture is the second most common form of CS accounting for 20-30% of all NSC cases. The etiology of coronal NSC (cNSC) is not well understood, although the published literature suggests that it is a multifactorial condition. About 5-14% of coronal craniosynostosis patients have a positive family history, with a specific genetic etiology identified in \>25% of cNSC cases, suggesting a strong genetic component in the pathogenesis of this birth defect. The causes for cNSC and its phenotypic heterogeneity remain largely unknown. An international team of investigators will generate large genomic and gene expression datasets on samples from patients with cNSC. State-of-the-art imaging, genetic, and developmental and systems biology approaches will be used to quantitatively model novel pathways and networks involved in the development of cNSC. Novel variant-, gene- and network-level analyses will be performed on the genomic data obtained from cNSC cases, their relatives, and controls to identify novel variants and genetic regions associated with cNCS. Quantitative, analytical, and functional validations of these predictions will provide insights into the etiology and possible therapeutic targets for CS and potentially other bone-related disorders.
Primary Outcome
Phenotype-genotype-gene expression correlations among cohorts of cases of coronal nonsyndromic craniosynostosis and genotype-gene expression correlations among controls will be analyzed and compared.
Conditions Studied
Interventions
- PROCEDURE Skin Biopsy
- OTHER Craniosynostosis Network Environmental Survey
- OTHER 2D/3D Photography
- PROCEDURE Buccal Swab Cell Sampling
- PROCEDURE Blood sampling
Study Locations (20)
New York
- Birth Defect Registries of New York State - Albany
- New York University - New York
- Icahn School of Medicine at Mount Sinai - New York
Texas
- Seton Family of Hospitals - Austin
- Medical City Children's Hospital - Dallas
- University of Texas at Southwestern - Dallas
Pennsylvania
- Pennsylvania State Milton S. Hershey Medical Center - Hershey
- Pennsylvania State University - University Park
California
- The International Craniosynostosis Consortium at University of California at Davis - Davis
Connecticut
- Yale University - Hartford
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Iowa
- National Birth Defects Prevention Study at University of Iowa - Iowa City
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,145 participants |
| Start Date | 2015-01-13 |
| Est. Completion | 2028-01-31 |
What the registry record for NCT03025763 still lists
NCT03025763 is an observational study that tracks outcomes without assigning an intervention. Its 2,145 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Craniosynostosis appearing as the primary indexed condition, and to 5 interventions - of which Skin Biopsy is the first listed.
NCT03025763 names 20 study sites across 15 states, led by New York, Texas, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03025763 about?
NCT03025763 is a clinical study titled "Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones". Craniosynostosis (CS) is a common malformation occurring in \~4 per 10,000 live births in which the sutures between skull bones close too early, causing long-term problems with brain and skull growth. Infants with CS typically require extensive surgical treatment and may experience many perioperativ...
What is the current status of trial NCT03025763?
This trial is currently active not recruiting. The enrollment target is 2,145 participants. The study started on 2015-01-13. Estimated completion is 2028-01-31.
What conditions does trial NCT03025763 study?
This clinical trial studies the following conditions: Craniosynostosis.
What interventions are being tested in trial NCT03025763?
The interventions under investigation include: Skin Biopsy (PROCEDURE), Craniosynostosis Network Environmental Survey (OTHER), 2D/3D Photography (OTHER), Buccal Swab Cell Sampling (PROCEDURE), Blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT03025763?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03025763 being conducted?
This trial has 20 study locations across California, Connecticut, Illinois, Iowa, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Craniosynostosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI